Diabetes patients will be able to take insulin from inhalers, this drug will soon come to India

If you are a diabetic patient and you are afraid of insulin injections, then this news is for you. Insulin inhaler is coming in the market soon.

New Delhi: The Indian regulator Central Drugs Standard Control Organisation (CDSCO) has given approval to drug maker Cipla to distribute and market inhaled insulin called Afreza in the country. Afreza has been developed by Mankind Corporation and is used to improve glycemic control, especially for adult patients with diabetes mellitus.

This new drug will reduce the need for diabetic patients to take insulin injections, and it may be a better option for those who have a fear or problem with needles. Cipla aims to make this inhaler insulin more accessible so that millions of people can take control of their health better.

What is Afrezza and how does it work?

Afrezza is a fast-acting insulin that is taken from an inhaler. Currently, insulin is given as an injection, but Afreja is taken before meals and it enters directly into the lungs, where it rapidly dissolves to deliver insulin into the blood. Cipla says that the effect starts to show in just 12 minutes of taking Afreja, and it controls the rapid rise in blood sugar levels. Its effect lasts for about two to three hours, and it is similar to the effect of insulin.

Company Purpose

"We are offering a convenient solution for people suffering from diabetes which will be especially beneficial for those who are afraid of needles or cannot use them properly," said Umang Vohra, Managing Director and Global CEO, Cipla. Will help to control.

Afrezza is being used in the US for 10

Afrezza has already been available in the US for more than 10 years and is benefiting thousands of patients there. Now Mankind Corporation will supply Afrezza to Cipla, and Cipla will sell it in the Indian market. Afreja's arrival in India could provide a new direction in diabetes treatment practices and be a new option for millions of diabetics in India.

Disclaimer: Dear reader, thank you for reading our news. This news has been written only for the purpose of making you aware. We have taken the help of home remedies and general information in writing it. If you read anything related to your health anywhere, then consult a doctor before adopting it.